Print Friendly, PDF & Email

Pipeline and Clinical Trials

Vetigenics has a promising pipeline of products aimed at addressing cancer and other chronic pet diseases. With a focus on R&D and a commitment to developing novel approaches, Vetigenics is well-positioned to address a range of challenges facing the pet health industry.

Explore Details About our Clinical Trials:

For CTLA4 (VGS-001) trial in canine oral melanoma, visit:

  North Carolina State University – Actively Recruiting

  University of Missouri – Actively Recruiting

For PD-1 (VGS-002) trial in canine urothelial carcinoma, visit:
  Ethos Veterinary Health – Actively Recruiting

  Bridge Animal Referral Center (BARC) – Actively Recruiting

Share this page

.elementor-icon, a.skip-link{display:none!important;} .print-img img{margin:0 auto!important} .elementor-element-23751c5 img.attachment-full {max-width:100%!important} .dogs.print-no{display:none!important;} .print-text-align-center{text-align:center!important;} { display: none!important; }